Other Species / Isoforms
  XRCC1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K129-ub
EKRWDRVkIVCSQPY
0 4
XRCC1 (human) EKRWDRVkIVCSQPY K129-ub
XRCC1 (mouse) EKRWDRVKIVCSQPY K131
XRCC1 (rat) EKRWDRVKIVCSQPY K131
K138-ub
VCSQPYSkDsPFGLS
0 1
XRCC1 (human) VCSQPYSkDsPFGLS K138-ub
XRCC1 (mouse) VCSQPYSKDSPYGLS K140
XRCC1 (rat) VCSQPYSKDSPYGLS K140
S140-p
SQPYSkDsPFGLSFV
0 2
XRCC1 (human) SQPYSkDsPFGLSFV S140-p
XRCC1 (mouse) SQPYSKDSPYGLSFV S142
XRCC1 (rat) SQPYSKDSPYGLSFV S142
S151-p
LSFVRFHsPPDKDEA
0 1
XRCC1 (human) LSFVRFHsPPDKDEA S151-p
XRCC1 (mouse) LSFVKFHSPPDKDEA S153
XRCC1 (rat) LSFVKFHSPPDKDEA S153
S162-p
KDEAEAPsQKVTVTk
0 1
XRCC1 (human) KDEAEAPsQKVTVTk S162-p
XRCC1 (mouse) KDEAEATSQKVTVTK S164
XRCC1 (rat) KDEAEAPSQKVTVTK S164
K169-ac
sQKVTVTkLGQFRVk
0 9
XRCC1 (human) sQKVTVTkLGQFRVk K169-ac
XRCC1 (mouse) SQKVTVTKLGQFRVK K171
XRCC1 (rat) SQKVTVTKLGQFRVK K171
K169-ub
sQKVTVTkLGQFRVk
0 4
XRCC1 (human) sQKVTVTkLGQFRVk K169-ub
XRCC1 (mouse) SQKVTVTKLGQFRVK K171
XRCC1 (rat) SQKVTVTKLGQFRVK K171
K176-sm
kLGQFRVkEEDESAN
1 4
XRCC1 (human) kLGQFRVkEEDESAN K176-sm
XRCC1 (mouse) KLGQFRVKEEDDSAN K178
XRCC1 (rat) KLGQFRVKEEDDSAN K178
S184-p
EEDESANsLRPGALF
Upstream
1 1
Kinase, in vitro:
  • Chk2 (human)
XRCC1 (human) EEDESANsLRPGALF S184-p
XRCC1 (mouse) EEDDSANSLKPGALF S186
XRCC1 (rat) EEDDSANSLRPGALF S186
T198-p
FFSRINKtsPVtAsD
0 3
XRCC1 (human) FFSRINKtsPVtAsD T198-p
XRCC1 (mouse) FFSRINKTSSASTSD T200
XRCC1 (rat) FFNRINKAASASASD A200
S199-p
FSRINKtsPVtAsDP
0 8
XRCC1 (human) FSRINKtsPVtAsDP S199-p
XRCC1 (mouse) FSRINKTSSASTSDP S201
XRCC1 (rat) FNRINKAASASASDP A201
T202-p
INKtsPVtAsDPAGP
Upstream
0 3
Treatment
  • nocodazole
XRCC1 (human) INKtsPVtAsDPAGP T202-p
XRCC1 (mouse) INKTSSASTSDPAGP S204
XRCC1 (rat) INKAASASASDPAGP S204
S204-p
KtsPVtAsDPAGPsy
Upstream
0 1
Treatment
  • nocodazole
XRCC1 (human) KtsPVtAsDPAGPsy S204-p
XRCC1 (mouse) KTSSASTSDPAGPSY S206
XRCC1 (rat) KAASASASDPAGPSY S206
S210-p
AsDPAGPsyAAATLQ
Upstream
1 0
Kinase, in vitro:
  • Chk2 (human)
XRCC1 (human) AsDPAGPsyAAATLQ S210-p
XRCC1 (mouse) TSDPAGPSYAAATLQ S212
XRCC1 (rat) ASDPAGPSYAAATLQ S212
Y211-p
sDPAGPsyAAATLQA
0 2
XRCC1 (human) sDPAGPsyAAATLQA Y211-p
XRCC1 (mouse) SDPAGPSYAAATLQA Y213
XRCC1 (rat) SDPAGPSYAAATLQA Y213
S226-p
SSAASSAsPVsRAIG
0 20
XRCC1 (human) SSAASSAsPVsRAIG S226-p
XRCC1 (mouse) SSAASSAsPVPKVVG S228-p
XRCC1 (rat) SSAASSASPVPKVGG S228
S229-p
ASSAsPVsRAIGsts
0 2
XRCC1 (human) ASSAsPVsRAIGsts S229-p
XRCC1 (mouse) ASSAsPVPKVVGSSS P231
XRCC1 (rat) ASSASPVPKVGGSSS P231
S234-p
PVsRAIGstsKPQEs
0 2
XRCC1 (human) PVsRAIGstsKPQEs S234-p
XRCC1 (mouse) PVPKVVGSSSKPQEP S236
XRCC1 (rat) PVPKVGGSSSKLQEP S236
T235-p
VsRAIGstsKPQEsP
0 1
XRCC1 (human) VsRAIGstsKPQEsP T235-p
XRCC1 (mouse) VPKVVGSSSKPQEPP S237
XRCC1 (rat) VPKVGGSSSKLQEPP S237
S236-p
sRAIGstsKPQEsPK
0 2
XRCC1 (human) sRAIGstsKPQEsPK S236-p
XRCC1 (mouse) PKVVGSSSKPQEPPK S238
XRCC1 (rat) PKVGGSSSKLQEPPK S238
S241-p
stsKPQEsPKGKRkL
Upstream
0 37
Treatment
  • EGF
  • nocodazole
XRCC1 (human) stsKPQEsPKGKRkL S241-p
XRCC1 (mouse) SSSKPQEPPKGKRKL P243
XRCC1 (rat) SSSKLQEPPKGKRKL P243
K247-sm
EsPKGKRkLDLNQEE
0 1
XRCC1 (human) EsPKGKRkLDLNQEE K247-sm
XRCC1 (mouse) EPPKGKRKLDLSLED K249
XRCC1 (rat) EPPKGKRKLDLGLED K249
K256-ac
DLNQEEKktPskPPA
0 2
XRCC1 (human) DLNQEEKktPskPPA K256-ac
XRCC1 (mouse) DLSLEDRKPPSKPsA K258
XRCC1 (rat) DLGLEDKKPPSKPSA K258
K256-sm
DLNQEEKktPskPPA
0 1
XRCC1 (human) DLNQEEKktPskPPA K256-sm
XRCC1 (mouse) DLSLEDRKPPSKPsA K258
XRCC1 (rat) DLGLEDKKPPSKPSA K258
T257-p
LNQEEKktPskPPAQ
Upstream
0 12
Treatment
  • LRRK2-IN-1
  • nocodazole
XRCC1 (human) LNQEEKktPskPPAQ T257-p
XRCC1 (mouse) LSLEDRKPPSKPsAG P259
XRCC1 (rat) LGLEDKKPPSKPSAG P259
S259-p
QEEKktPskPPAQLs
0 3
XRCC1 (human) QEEKktPskPPAQLs S259-p
XRCC1 (mouse) LEDRKPPSKPsAGPS S261
XRCC1 (rat) LEDKKPPSKPSAGPP S261
K260-ac
EEKktPskPPAQLsP
Upstream
Downstream
1 3
Effects on Modified Protein
  • protein degradation
Treatment
  • cycloheximide
  • selisistat
XRCC1 (human) EEKktPskPPAQLsP K260-ac
XRCC1 (mouse) EDRKPPSKPsAGPST K262
XRCC1 (rat) EDKKPPSKPSAGPPA K262
P262
KktPskPPAQLsPsV
0 1
XRCC1 (human) KktPskPPAQLsPsV P262
XRCC1 (mouse) RKPPSKPsAGPSTLK S264-p
XRCC1 (rat) KKPPSKPSAGPPAPK S264
S266-p
skPPAQLsPsVPkRP
Upstream
0 19
Treatment
  • ischemia
XRCC1 (human) skPPAQLsPsVPkRP S266-p
XRCC1 (mouse) PPSKPsAGPSTLKRP G266
XRCC1 (rat) PPSKPSAGPPAPKRP G266
S268-p
PPAQLsPsVPkRPKL
Upstream
0 6
Treatment
  • nocodazole
XRCC1 (human) PPAQLsPsVPkRPKL S268-p
XRCC1 (mouse) SKPsAGPSTLKRPKL S268
XRCC1 (rat) SKPSAGPPAPKRPKL P268
K271-ac
QLsPsVPkRPKLPAP
0 2
XRCC1 (human) QLsPsVPkRPKLPAP K271-ac
XRCC1 (mouse) sAGPSTLKRPKLSVP K271
XRCC1 (rat) SAGPPAPKRPKLPVP K271
T279-p
RPKLPAPtRtPAtAP
0 1
XRCC1 (human) RPKLPAPtRtPAtAP T279-p
XRCC1 (mouse) RPKLSVPSRTPAAAP S279
XRCC1 (rat) RPKLPVPSRTPAATP S279
T281-p
KLPAPtRtPAtAPVP
0 2
XRCC1 (human) KLPAPtRtPAtAPVP T281-p
XRCC1 (mouse) KLSVPSRTPAAAPAS T281
XRCC1 (rat) KLPVPSRTPAATPAS T281
T284-p
APtRtPAtAPVPARA
Upstream
Downstream
1 1
Effects on Modified Protein
  • activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • cell growth, altered
Kinase, in vitro:
  • Chk2 (human)
Putative in vivo kinases:
  • Chk2 (human)
Treatment
  • Chk2_inhibitor_II
  • H2O2
  • MMS
view more >
XRCC1 (human) APtRtPAtAPVPARA T284-p
XRCC1 (mouse) VPSRTPAAAPASTPA A284
XRCC1 (rat) VPSRTPAATPASTPA A284
T296-p
ARAQGAVtGkPRGEG
0 1
XRCC1 (human) ARAQGAVtGkPRGEG T296-p
XRCC1 (mouse) TPAQRAVPGKPRGEG P296
XRCC1 (rat) TPAQKAVPGKPRGEG P296
T296-ga
ARAQGAVtGkPRGEG
0 1
XRCC1 (human) ARAQGAVtGkPRGEG T296-ga
XRCC1 (mouse) TPAQRAVPGKPRGEG P296
XRCC1 (rat) TPAQKAVPGKPRGEG P296
K298-ac
AQGAVtGkPRGEGTE
Upstream
Downstream
1 9
Effects on Modified Protein
  • protein degradation
Treatment
  • cycloheximide
  • selisistat
XRCC1 (human) AQGAVtGkPRGEGTE K298-ac
XRCC1 (mouse) AQRAVPGKPRGEGTE K298
XRCC1 (rat) AQKAVPGKPRGEGTE K298
R310-m1
GTEPRRPrAGPEELG
0 1
XRCC1 (human) GTEPRRPrAGPEELG R310-m1
XRCC1 (mouse) GTEPRGARTGPQELG R310
XRCC1 (rat) GTEPRGARAGPQELG R310
K341-ub
FRSELRDkALELGAk
0 3
XRCC1 (human) FRSELRDkALELGAk K341-ub
XRCC1 (mouse) FRSELRDKALELGAK K341
XRCC1 (rat) FRSELRDKALELGAK K341
K348-ub
kALELGAkYRPDWTR
0 1
XRCC1 (human) kALELGAkYRPDWTR K348-ub
XRCC1 (mouse) KALELGAKYRPDWTP K348
XRCC1 (rat) KALELGAKYRPDWTP K348
S357-p
RPDWTRDstHLICAF
1 1
XRCC1 (human) RPDWTRDstHLICAF S357-p
XRCC1 (mouse) RPDWTPDSTHLICAF S357
XRCC1 (rat) RPDWTPDSTHLICAF S357
T358-p
PDWTRDstHLICAFA
Downstream
1 1
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • DNA repair, induced
XRCC1 (human) PDWTRDstHLICAFA T358-p
XRCC1 (mouse) PDWTPDSTHLICAFA T358
XRCC1 (rat) PDWTPDSTHLICAFA T358
T367-p
LICAFANtPKysQVL
Downstream
1 2
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • DNA repair, induced
XRCC1 (human) LICAFANtPKysQVL T367-p
XRCC1 (mouse) LICAFANTPKYSQVL T367
XRCC1 (rat) LICAFANTPKYSQVL T367
Y370-p
AFANtPKysQVLGLG
0 1
XRCC1 (human) AFANtPKysQVLGLG Y370-p
XRCC1 (mouse) AFANTPKYSQVLGLG Y370
XRCC1 (rat) AFANTPKYSQVLGLG Y370
S371-p
FANtPKysQVLGLGG
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • DNAPK (human)
Treatment
  • ionizing_radiation
  • wortmannin
XRCC1 (human) FANtPKysQVLGLGG S371-p
XRCC1 (mouse) FANTPKYSQVLGLGG S371
XRCC1 (rat) FANTPKYSQVLGLGG S371
K383-ub
LGGRIVRkEWVLDCH
0 1
XRCC1 (human) LGGRIVRkEWVLDCH K383-ub
XRCC1 (mouse) LGGRIVRKEWVLDCH K383
XRCC1 (rat) LGGRIVRKEWVLDCY K383
S408-p
YLMAGPGsssEEDEA
Upstream
Downstream
1 5
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
XRCC1 (human) YLMAGPGsssEEDEA S408-p
XRCC1 (mouse) YLMAGLGSSSEDEGD S408
XRCC1 (rat) YLMAGLGSSSEDEGD S408
S409-p
LMAGPGsssEEDEAs
Upstream
Downstream
1 5
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
XRCC1 (human) LMAGPGsssEEDEAs S409-p
XRCC1 (mouse) LMAGLGSSSEDEGDS S409
XRCC1 (rat) LMAGLGSSSEDEGDS S409
S410-p
MAGPGsssEEDEAsH
Upstream
Downstream
1 5
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
XRCC1 (human) MAGPGsssEEDEAsH S410-p
XRCC1 (mouse) MAGLGSSSEDEGDSH S410
XRCC1 (rat) MAGLGSSSEDEGDSH S410
S416-p
ssEEDEAsHsGGsGD
Upstream
Downstream
0 4
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
XRCC1 (human) ssEEDEAsHsGGsGD S416-p
XRCC1 (mouse) SSEDEGDSHSESGED S416
XRCC1 (rat) SSEDEGDSHSESGED S416
S418-p
EEDEAsHsGGsGDEA
Upstream
Downstream
0 3
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
XRCC1 (human) EEDEAsHsGGsGDEA S418-p
XRCC1 (mouse) EDEGDSHSESGEDEA S418
XRCC1 (rat) EDEGDSHSESGEDEA S418
S421-p
EAsHsGGsGDEAPKL
Upstream
Downstream
0 4
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
XRCC1 (human) EAsHsGGsGDEAPKL S421-p
XRCC1 (mouse) GDSHSESGEDEAPKL G421
XRCC1 (rat) GDSHSESGEDEAPKL G421
K431-ac
EAPKLPQkQPQTKtK
Upstream
Downstream
1 1
Effects on Modified Protein
  • protein degradation
Treatment
  • cycloheximide
  • selisistat
XRCC1 (human) EAPKLPQkQPQTKtK K431-ac
XRCC1 (mouse) EAPKLPQKRPQPKAK K431
XRCC1 (rat) EAPKLPRKRPQPKAK K431
K431-ub
EAPKLPQkQPQTKtK
0 1
XRCC1 (human) EAPKLPQkQPQTKtK K431-ub
XRCC1 (mouse) EAPKLPQKRPQPKAK K431
XRCC1 (rat) EAPKLPRKRPQPKAK K431
T437-p
QkQPQTKtKPtQAAG
0 1
XRCC1 (human) QkQPQTKtKPtQAAG T437-p
XRCC1 (mouse) QKRPQPKAKTQAAGP A437
XRCC1 (rat) RKRPQPKAKTQAAGP A437
T440-p
PQTKtKPtQAAGPss
0 7
XRCC1 (human) PQTKtKPtQAAGPss T440-p
XRCC1 (mouse) RPQPKAKTQAAGPss T439
XRCC1 (rat) RPQPKAKTQAAGPSs T439
T440-ga
PQTKtKPtQAAGPss
0 1
XRCC1 (human) PQTKtKPtQAAGPss T440-ga
XRCC1 (mouse) RPQPKAKTQAAGPss T439
XRCC1 (rat) RPQPKAKTQAAGPSs T439
S446-p
PtQAAGPssPQKPPt
0 20
XRCC1 (human) PtQAAGPssPQKPPt S446-p
XRCC1 (mouse) KTQAAGPssPPRPPt S445-p
XRCC1 (rat) KTQAAGPSsPPRPPt S445
S446-ga
PtQAAGPssPQKPPt
0 1
XRCC1 (human) PtQAAGPssPQKPPt S446-ga
XRCC1 (mouse) KTQAAGPSsPPRPPt S445
XRCC1 (rat) KTQAAGPSsPPRPPt S445
S447-p
tQAAGPssPQKPPtP
Upstream
0 58
Treatment
  • EGF
XRCC1 (human) tQAAGPssPQKPPtP S447-p
XRCC1 (mouse) TQAAGPssPPRPPtP S446-p
XRCC1 (rat) TQAAGPSsPPRPPtP S446-p
S447-ga
tQAAGPssPQKPPtP
0 1
XRCC1 (human) tQAAGPssPQKPPtP S447-ga
XRCC1 (mouse) TQAAGPsSPPRPPtP S446
XRCC1 (rat) TQAAGPSSPPRPPtP S446
T453-p
ssPQKPPtPEEtKAA
Upstream
1 89
Treatment
  • LRRK2-IN-1
XRCC1 (human) ssPQKPPtPEEtKAA T453-p
XRCC1 (mouse) ssPPRPPtPKETKAP T452-p
XRCC1 (rat) SsPPRPPtPEETKAP T452-p
T453-ga
ssPQKPPtPEEtKAA
0 1
XRCC1 (human) ssPQKPPtPEEtKAA T453-ga
XRCC1 (mouse) ssPPRPPTPKETKAP T452
XRCC1 (rat) SsPPRPPTPEETKAP T452
T457-p
KPPtPEEtKAAsPVL
0 13
XRCC1 (human) KPPtPEEtKAAsPVL T457-p
XRCC1 (mouse) RPPtPKETKAPSPGP T456
XRCC1 (rat) RPPtPEETKAPSPGP T456
S461-p
PEEtKAAsPVLQEDI
1 13
XRCC1 (human) PEEtKAAsPVLQEDI S461-p
XRCC1 (mouse) PKETKAPSPGPQDNs S460
XRCC1 (rat) PEETKAPSPGPQDNS S460
I468
sPVLQEDIDIEGVQs
0 1
XRCC1 (human) sPVLQEDIDIEGVQs I468
XRCC1 (mouse) SPGPQDNsDtEGEES S467-p
XRCC1 (rat) SPGPQDNSDTDGEQS S467
I470
VLQEDIDIEGVQsEG
0 1
XRCC1 (human) VLQEDIDIEGVQsEG I470
XRCC1 (mouse) GPQDNsDtEGEESEG T469-p
XRCC1 (rat) GPQDNSDTDGEQSEG T469
S475-p
IDIEGVQsEGQDNGA
Upstream
Downstream
2 8
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
XRCC1 (human) IDIEGVQsEGQDNGA S475-p
XRCC1 (mouse) sDtEGEESEGRDNGA S474
XRCC1 (rat) SDTDGEQSEGRDNGA S474
S485-p
QDNGAEDsGDtEDEL
Upstream
Downstream
2 15
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
  • CK2A2 (human)
XRCC1 (human) QDNGAEDsGDtEDEL S485-p
XRCC1 (mouse) RDNGAEDsGDtEDEL S484-p
XRCC1 (rat) RDNGAEDsGDtEDEL S484-p
T488-p
GAEDsGDtEDELRRV
Upstream
Downstream
3 15
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
  • CK2A2 (human)
XRCC1 (human) GAEDsGDtEDELRRV T488-p
XRCC1 (mouse) GAEDsGDtEDELRRV T487-p
XRCC1 (rat) GAEDsGDtEDELRRV T487-p
Y515-p
EENGEDPyAGstDEN
Upstream
Downstream
0 1
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
XRCC1 (human) EENGEDPyAGstDEN Y515-p
XRCC1 (mouse) EENGEDPYAGstDEN Y514
XRCC1 (rat) EENGEDPYAGSTDEN Y514
S518-p
GEDPyAGstDENtDs
Upstream
Downstream
3 10
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
  • CK2A2 (human)
Treatment
  • MMS
  • TBB
XRCC1 (human) GEDPyAGstDENtDs S518-p
XRCC1 (mouse) GEDPYAGstDENTDs S517-p
XRCC1 (rat) GEDPYAGSTDENTDS S517
T519-p
EDPyAGstDENtDsE
Upstream
Downstream
2 9
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
  • CK2A2 (human)
Treatment
  • MMS
  • TBB
XRCC1 (human) EDPyAGstDENtDsE T519-p
XRCC1 (mouse) EDPYAGstDENTDsE T518-p
XRCC1 (rat) EDPYAGSTDENTDSE T518
T523-p
AGstDENtDsEEHQE
Upstream
Downstream
3 7
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
  • CK2A2 (human)
Treatment
  • MMS
  • TBB
XRCC1 (human) AGstDENtDsEEHQE T523-p
XRCC1 (mouse) AGstDENTDsEtPSE T522
XRCC1 (rat) AGSTDENTDSEAPSE T522
S525-p
stDENtDsEEHQEPP
Upstream
Downstream
1 5
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
XRCC1 (human) stDENtDsEEHQEPP S525-p
XRCC1 (mouse) stDENTDsEtPSEAD S524-p
XRCC1 (rat) STDENTDSEAPSEAD S524
E527
DENtDsEEHQEPPDL
0 1
XRCC1 (human) DENtDsEEHQEPPDL E527
XRCC1 (mouse) DENTDsEtPSEADLP T526-p
XRCC1 (rat) DENTDSEAPSEADLP A526
S578-p
GELEDYMsDRVQFVI
Upstream
Downstream
0 1
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • CK2A1 (human)
XRCC1 (human) GELEDYMsDRVQFVI S578-p
XRCC1 (mouse) GELEDYMNERVQFVI N576
XRCC1 (rat) GELEDYMSDRVQFVI S576
K620-ub
YSCNEKQkLLPHQLy
0 1
XRCC1 (human) YSCNEKQkLLPHQLy K620-ub
XRCC1 (mouse) YSCNEKQKLLPHQLY K618
XRCC1 (rat) YSCNEKQKLLPHQLY K618
Y627-p
kLLPHQLyGVVPQA_
0 2
XRCC1 (human) kLLPHQLyGVVPQA_ Y627-p
XRCC1 (mouse) KLLPHQLYGVVPQA_ Y625
XRCC1 (rat) KLLPHQLYGVVPQA_ Y625